Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Paula Greter: Access and Innovation in Hemophilia through ERAH2026
Paula Greter/LinkedIn
May 23, 2026, 01:51

Paula Greter: Access and Innovation in Hemophilia through ERAH2026

Paula Greter, Commercial Strategy and Market Access Director at Roche Brazil, shared a post on LinkedIn:

”Participating in ERAH2026 truly reinforced what drives me at Roche Farma Brasil: our purpose to transform science into hope and meaningful quality of life for families.

This is an unyielding pursuit of solutions that challenge the impossible.

In our long-term journey with the community, hemophilia remains a core priority, keeping us dedicated to securing two essential pillars: access and innovation.

To drive the future forward , we continually invest in developing next-generation approaches.

Alongside this, we take great pride in our humanitarian aid program in partnership with the WFH, bringing access to communities in over 30 countries.

Our commitment is continuous: ensuring that these patients’ lives keep moving forward, always.

Let’s keep this momentum alive.”

Paula Greter: Access and Innovation in Hemophilia through ERAH2026

Stay updated with Hemostasis Today.

 

ERAH2026 Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Medicine Paula Greter thrombosis
NewsFeed